Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.56), $0.03 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.